6PIH image
Entry Detail
PDB ID:
6PIH
EMDB ID:
Keywords:
Title:
Hexameric ArnA cryo-EM structure
Biological Source:
PDB Version:
Deposition Date:
2019-06-26
Release Date:
2019-07-31
Method Details:
Experimental Method:
Resolution:
6.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Bifunctional polymyxin resistance protein ArnA
Chain IDs:A, B, C, D, E, F
Chain Length:300
Number of Molecules:6
Biological Source:Escherichia coli DH5[alpha]
Polymer Type:polypeptide(L)
Description:UDP-4-amino-4-deoxy-L-arabinose formyltransferase
Chain IDs:G, H, I, J, K, L
Chain Length:345
Number of Molecules:6
Biological Source:Escherichia coli DH5[alpha]
Ligand Molecules
Primary Citation
Cryo-electron microscopy structures of ArnA, a key enzyme for polymyxin resistance, revealed unexpected oligomerizations and domain movements.
J.Struct.Biol. 208 43 50 (2019)
PMID: 31344437 DOI: 10.1016/j.jsb.2019.07.009

Abstact

Gram-negative bacteria evade the attack of cationic antimicrobial peptides through modifying their lipid A structure in their outer membranes with 4-amino-4-deoxy-L-arabinose (Ara4N). ArnA is a crucial enzyme in the lipid A modification pathway and its deletion abolishes the polymyxin resistance of gram-negative bacteria. Previous studies by X-ray crystallography have shown that full-length ArnA forms a three-bladed propeller-shaped hexamer. Here, the structures of ArnA determined by cryo-electron microscopy (cryo-EM) reveal that ArnA exists in two 3D architectures, hexamer and tetramer. This is the first observation of a tetrameric ArnA. The hexameric cryo-EM structure is similar to previous crystal structures but shows differences in domain movements and conformational changes. We propose that ArnA oligomeric states are in a dynamic equilibrium, where the hexamer state is energetically more favorable, and its domain movements are important for cooperating with downstream enzymes in the lipid A-Ara4N modification pathway. The results provide us with new possibilities to explore inhibitors targeting ArnA.

Legend

Protein

Chemical

Disease

Primary Citation of related structures